Cell Culture Market worth $58.42 billion by 2031
The report "Cell Culture Market by Consumables [Media, Sera, Reagents (Supplements, Buffers)], Vessels (Plates, Flask, Roller Bottle), Equipment (Bioreactor, Filtration, Incubators, Centrifuge), Application (mAbs, Vaccines, CGT), Competition - Global Forecast to 2031", is projected to grow from USD 33.07 billion in 2026 and to reach USD 58.42 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 12.1% during the forecast period.
Browse 1000 market data Tables and 57 Figures spread through 765 Pages and in-depth TOC on "Cell Culture Market by Consumables [Media, Sera, Reagents (Supplements, Buffers)], Vessels (Plates, Flask, Roller Bottle), Equipment (Bioreactor, Filtration, Incubators, Centrifuge), Application (mAbs, Vaccines, CGT), Competition - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/cell-culture-market-media-sera-reagents-559.html
The cell culture market is experiencing steady growth, driven by rising biopharmaceutical R&D spending, increasing biologics and biosimilar production, expanding vaccine development, and growing investment in cell & gene therapy, regenerative medicine, and stem cell research. The need for reproducible, scalable, and contamination-controlled cell culture workflows is encouraging wider adoption of serum-free media, chemically defined media, optimized reagents, culture vessels, single-use bioreactors, filtration systems, and automated cell culture platforms. Technological advancements in 3D cell culture, organoids, spheroids, stem cell-derived models, and closed processing systems are improving experimental relevance, process consistency, and manufacturing efficiency. In addition, growing outsourcing of biologics production, viral vector manufacturing, cell banking, and advanced cell model development to CDMOs, CROs, and specialized service providers is expected to further support market growth.
By product, the consumables segment accounted for the largest share of the cell culture market in 2025.
By product, the cell culture market is segmented into consumables and equipment. Consumables are further segmented into sera, media, and reagents; vessels; and other consumables & accessories. Equipment is further categorized as bioreactors, storage equipment, and other equipment. The consumables segment dominated the market in 2025 and is expected to grow at a higher rate over the forecast period. The largest share of the segment is attributed to repetitive purchase of media & reagents, and growing R&D activities to develop and manufacture advanced therapies.
By end user, the pharmaceutical & biotechnology companies segment is estimated to register the highest growth in the cell culture market during the forecast period.
Based on end user, the cell culture market is segmented into pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, academic & research institutes, and other end users. The pharmaceutical & biotechnology companies segment is estimated to register the highest growth rate during the forecast period. The rising demand for advanced therapies, such as regenerative medicine, driven by the increasing prevalence of chronic diseases, is expected to boost growth in the pharmaceutical & biotechnology companies segment in the coming years.
North America accounted for the largest share of the cell culture market in 2025.
The cell culture market is divided into North America, Europe, Asia Pacific (APAC), Latin America (LATAM), the Middle East, and Africa. In 2025, North America held the largest share of the global cell culture market, supported by strong biopharmaceutical and biotechnology R&D activity, advanced biologics manufacturing infrastructure, established cell & gene therapy capabilities, and the presence of leading cell culture product suppliers, CDMOs, CROs, and academic research centers. The US remains the major contributor in the region due to its large base of pharmaceutical companies, government-funded research institutions, clinical trial networks, and advanced therapy developers. High adoption of serum-free media, chemically defined media, single-use bioreactors, culture vessels, filtration systems, cryopreservation products, and automated cell culture platforms further strengthens North America’s market leadership.
Key players in the cell culture market include Thermo Fisher Scientific Inc. (US), Danaher (US), Sartorius AG (Germany), Merck KGaA (Germany), Corning Incorporated (US), FUJIFILM Holdings Corporation (Japan), BD (US) Eppendorf SE (Germany), Lonza (Switzerland), Getinge AB (Sweden), Agilent Technologies, Inc. (US), HiMedia Laboratories (India), Miltenyi Biotec (Germany), STEMCELL Technologies (Canada), Solida Biotech GmbH (Germany), Caisson Labs (US), PromoCell GmbH (Germany), InvivoGen (France), PAN-Biotech (Germany), Cellexus (Scotland), Meissner Filtration Products Inc. (US), Adolf Kühner AG (Switzerland), Bio-Techne (US), Advancion Corporation (US), and BioSpherix, Ltd. (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Cell Culture Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
